YUN HEE AHN: Open Payments
NPI 1215327747 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 44 payments from 14 companies in 2025. Trend: 2023 $534 · 2024 $585 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $179 |
| Novo Nordisk Inc | 12 | $171 |
| Lilly USA, LLC | 2 | $112 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| ABBVIE INC. | 5 | $94 |
| Exact Sciences Corporation | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Amgen Inc. | 1 | $24 |
Products named: Kerendia, INSPIRE, ZEPBOUND, Ozempic, Rybelsus, QULIPTA, FARXIGA, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
